Author Correction: Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTENmRNA

Affiliations

• ¹ Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ² Oncology Division, Immunomic Therapeutics, Inc., Rockville, MD, USA.
• ³ Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
• ⁴ Hematology Division, Brigham and Women's Hospital, Boston, MA, USA.
• ⁵ Department of Medicine, Harvard Medical School, Boston, MA, USA.
• ⁶ Nanotechnology Engineering Program, University of Waterloo, Waterloo, Ontario, Canada.
• ⁷ David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
• ⁸ Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
• ⁹ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ¹⁰ Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ofarokhzad@bwh.harvard.edu.
• ¹¹ King Abdulaziz University, Jeddah, Saudi Arabia. ofarokhzad@bwh.harvard.edu.
• ¹² Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. bruce.zetter@childrens.harvard.edu.
• ¹³ Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. jshi@bwh.harvard.edu.